Rezolute Bio is focused on developing advanced therapies for metabolic diseases, specifically targeting conditions such as congenital hyperinsulinism and diabetic macular edema through clinical trials.
Enter your details and select criteria for the jobs you want to receive.
Lead the buildout and operation of Rezolute’s global pharmacovigilance function to support late-stage development, regulatory approval, and commercial launch of therapies for rare metabolic and endocrine disorders.
